ANGIODYNAMICS INC Annual Interest Expense in USD from 2009 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Angiodynamics Inc quarterly/annual Interest Expense history and growth rate from 2009 to 2023.
  • Angiodynamics Inc Interest Expense for the quarter ending May 31, 2024 was -$567K, a 163% decline year-over-year.
  • Angiodynamics Inc Interest Expense for the twelve months ending May 31, 2024 was -$1.61M, a 160% decline year-over-year.
  • Angiodynamics Inc annual Interest Expense for 2023 was -$1.61M, a 160% decline from 2022.
  • Angiodynamics Inc annual Interest Expense for 2022 was $2.7M, a 293% increase from 2021.
  • Angiodynamics Inc annual Interest Expense for 2021 was $688K, a 20.1% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.61M -$4.32M -160% Jun 1, 2023 May 31, 2024 10-K 2024-07-25
2022 $2.7M +$2.01M +293% Jun 1, 2022 May 31, 2023 10-K 2024-07-25
2021 $688K -$173K -20.1% Jun 1, 2021 May 31, 2022 10-K 2024-07-25
2020 $861K -$46K -5.07% Jun 1, 2020 May 31, 2021 10-K 2023-08-03
2019 $907K -$4.19M -82.2% Jun 1, 2019 May 31, 2020 10-K 2022-07-22
2018 $5.1M +$2.04M +66.5% Jun 1, 2018 May 31, 2019 10-K 2021-07-27
2017 $3.06M +$223K +7.86% Jun 1, 2017 May 31, 2018 10-K 2020-08-10
2016 $2.84M -$546K -16.1% Jun 1, 2016 May 31, 2017 10-K 2019-07-25
2015 $3.39M +$192K +6.01% Jun 1, 2015 May 31, 2016 10-K 2018-07-23
2014 $3.19M -$463K -12.7% Jun 1, 2014 May 31, 2015 10-K 2017-08-04
2013 $3.66M -$1.62M -30.6% Jun 1, 2013 May 31, 2014 10-K 2016-08-01
2012 $5.27M +$4.76M +938% Jun 1, 2012 May 31, 2013 10-K 2015-08-10
2011 $508K +$9K +1.8% Jun 1, 2011 May 31, 2012 10-K/A 2015-01-12
2010 $499K -$173K -25.7% Jun 1, 2010 May 31, 2011 10-K 2013-08-14
2009 $672K Jun 1, 2009 May 31, 2010 10-K 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.